Ángel L. Álvarez

Prof. Dr. Ángel L. Álvarez

Departamento de Bioquimica y Biologia Molecular, Universidad de Oviedo, Oviedo, Asturias, Spain
+1
orcid
Assistant Professor of Biochemistry and Molecular Biology at...

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2012 in Emerging Infectious Diseases
Verified
Journal Article
Open access
KDKevin P. Dalton
Kevin P. Dalton
INInés Nicieza
Inés Nicieza
ABAna Balseiro
Ana Balseiro
MMMaría A. Muguerza
María A. Muguerza
JRJoan M. Rosell
Joan M. Rosell
FPFrancisco Parra
Francisco Parra
Outbreaks of rabbit hemorrhagic disease have occurred recently in young rabbits on farms on the Iberian Peninsula where rabbits were previously vaccinated. Investigation identified a rabbit hemorrhagic disease virus variant genetically related to apathogenic rabbit caliciviruses. Improved antivirus strategies are needed to slow the spread of this pathogen.

1 May 2010 in Food Chemistry
Verified
Journal Article
Open access
BSBelén Suárez
Belén Suárez
Ángel L. ÁlvarezÁngel L. Álvarez
Ángel L. Álvarez
YGYolanda Diñeiro García
Yolanda Diñeiro García
GBGloria del Barrio
Gloria del Barrio
APAnna Picinelli-Lobo
Anna Picinelli-Lobo
FPFrancisco Parra
Francisco Parra
Methanolic and acetonic extracts of apple pomace were evaluated for phenolic profiles, antioxidant properties and antiviral effect against herpes simplex virus type 1 (HSV-1) and 2 (HSV-2). Acetone extraction yielded the higher amounts of phenolic compounds. The extraction method influenced the phenolic composition although antioxidant activity correlated weakly with phenols concentration. Among the polyphenols analysed, quercetin glycosides were the most important family, followed by dihydrochalcones. Apple pomace extracts were able to inhibit both HSV-1 and HSV-2 replication in Vero cells by more than 50%, at non-cytotoxic concentrations. Selectivity indexes (SI) ranged from 9.5 to 12.2.

1 September 2016 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
BNBeatriz Novoa
Beatriz Novoa
Alejandro RomeroAlejandro Romero
Alejandro Romero
Ángel L. ÁlvarezÁngel L. Álvarez
Ángel L. Álvarez
RMRebeca Moreira
Rebeca Moreira
PPPatricia Pereiro
Patricia Pereiro
AFAntonio Figueras
Antonio Figueras
Little is known about the antiviral response in mollusks. As in other invertebrates, the interferon signaling pathways have not been identified, and in fact, there is a debate about whether invertebrates possess antiviral immunity similar to that of vertebrates. In marine bivalves, due to their filtering activity, interaction with putative pathogens, including viruses, is very high, suggesting that they should have mechanisms to address these infections. In this study, we confirmed that constitutively expressed molecules in naive mussels confer resistance in oysters to ostreid herpesvirus 1 (OsHV-1) when oyster hemocytes are incubated with mussel hemolymph. Using a proteomic approach, myticin C peptides were identified in both mussel hemolymph and hemocytes. Myticins, antimicrobial peptides that have been previously characterized, were constitutively expressed in a fraction of mussel hemocytes and showed antiviral activity against OsHV-1, suggesting that these molecules could be responsible for the antiviral activity of mussel hemolymph. For the first time, a molecule from a bivalve has shown antiviral activity against a virus affecting mollusks. Moreover, myticin C peptides showed antiviral activity against human herpes simplex viruses 1 (HSV-1) and 2 (HSV-2). In summary, our work sheds light on the invertebrate antiviral immune response with the identification of a molecule with potential biotechnological applications. IMPORTANCE Several bioactive molecules that have potential pharmaceutical or industrial applications have been identified and isolated from marine invertebrates. Myticin C, an antimicrobial peptide from the Mediterranean mussel ( Mytilus galloprovincialis ) that was identified by proteomic techniques in both mussel hemolymph and hemocytes, showed potential as an antiviral agent against ostreid herpesvirus 1 (OsHV-1), which represents a major threat to the oyster-farming sector. Both hemolymph from mussels and a myticin C peptide inhibited OsHV-1 replication in oyster hemocytes. Additionally, a modified peptide derived from myticin C or the nanoencapsulated normal peptide also showed antiviral activity against the human herpesviruses HSV-1 and HSV-2. Therefore, myticin C is an example of the biotechnological and therapeutic potential of mollusks.

20 December 2010 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
Ángel L. ÁlvarezÁngel L. Álvarez
Ángel L. Álvarez
SHSolomon Habtemariam
Solomon Habtemariam
MJMalindra Juan‐Badaturuge
Malindra Juan‐Badaturuge
CJCaroline Jackson
Caroline Jackson
FPFrancisco Parra
Francisco Parra

1 July 2015 in Antiviral Research
Verified
Journal Article
Closed access
Ángel L. ÁlvarezÁngel L. Álvarez
Ángel L. Álvarez
SHSolomon Habtemariam
Solomon Habtemariam
AMAhmed Abddel Moneim
Ahmed Abddel Moneim
SMSantiago Melón
Santiago Melón
KDKevin P. Dalton
Kevin P. Dalton
FPFrancisco Parra
Francisco Parra

11 January 2015 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
KDKevin P. Dalton
Kevin P. Dalton
JAJoana Abrantes
Joana Abrantes
Ana LopesAna Lopes
Ana Lopes
INI. Nicieza
I. Nicieza
Ángel L. ÁlvarezÁngel L. Álvarez
Ángel L. Álvarez
FPFrancisco Parra
Francisco Parra